(Q38388436)

2 September 2017

title

Association of non-alcoholic fatty liver disease with impaired endothelial function by flow-mediated dilation: A meta-analysis (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

2 September 2017

0 references

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1 reference

1 reference

Yu Fan

1

1 reference

2 September 2017

Feifei Wei

series ordinal

2

1 reference

2 September 2017

Yongjing Zhou

series ordinal

3

1 reference

2 September 2017

Heng Zhang

series ordinal

4

1 reference

2 September 2017

publication date

15 July 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

46

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

E165-73

1 reference

Pathogenesis of non-alcoholic fatty liver disease.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Prognostic value of endothelial function in patients with atherosclerosis: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

The assessment of endothelial function: from research into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Assessment of endothelial function in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

A re-evaluation of random-effects meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Flow-mediated dilatation: a review of techniques and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Obesity is associated with impaired endothelial function in the postprandial state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Endothelial function and weight loss in obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Insulin resistance in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Oxidative stress is activated by free fatty acids in cultured human hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12554

21 January 2018

Identifiers

DOI

10.1111/HEPR.12554

1 reference

2 September 2017

1 reference